Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.180
+0.010 (0.85%)
Jun 9, 2026, 12:08 PM EDT - Market open
Bionano Genomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28.74 | 28.51 | 30.78 | 36.12 | 27.8 | 17.98 | |
Revenue Growth (YoY) | 0.96% | -7.37% | -14.79% | 29.90% | 54.62% | 111.47% |
Cost of Revenue | 15.24 | 15.32 | 30.4 | 26.55 | 21.86 | 14.11 |
Gross Profit | 13.5 | 13.19 | 0.38 | 9.57 | 5.95 | 3.87 |
Selling, General & Admin | 34.13 | 35.15 | 51.86 | 92.76 | 88.6 | 58.49 |
Research & Development | 12.14 | 11.37 | 24.8 | 54.03 | 49.05 | 22.49 |
Other Operating Expenses | - | - | 27.71 | 78.02 | - | - |
Total Operating Expenses | 46.27 | 46.52 | 104.36 | 224.81 | 137.64 | 80.98 |
Operating Income | -32.77 | -33.34 | -103.98 | -215.25 | -131.7 | -77.1 |
Interest Income | 1.04 | 1.11 | 2.1 | 3.31 | 1.51 | 0.24 |
Interest Expense | - | - | - | - | -0.3 | -0.93 |
Other Non-Operating Income (Expense) | 0.2 | 5.9 | -10.1 | -20.5 | -0.22 | -0.36 |
Total Non-Operating Income (Expense) | 1.24 | 7.01 | -8 | -17.19 | 0.99 | -1.05 |
Pretax Income | -31.53 | -26.33 | -111.98 | -232.43 | -130.71 | -78.15 |
Provision for Income Taxes | 0.07 | 0.07 | 0.03 | 0.06 | 1.88 | -5.72 |
Net Income | -31.6 | -26.4 | -112.02 | -232.49 | -132.6 | -72.44 |
Net Income to Common | -31.6 | -26.4 | -112.02 | -232.49 | -132.6 | -72.44 |
Shares Outstanding (Basic) | 1,784 | 5 | 1 | 1 | 0 | 0 |
Shares Outstanding (Diluted) | 1,784 | 5 | 1 | 1 | 0 | 0 |
Shares Change (YoY) | 273.04% | 328.40% | 123.37% | 18.05% | 4.49% | 165.50% |
EPS (Basic) | -4.37 | -4.85 | -88.13 | -408.60 | -274.80 | -156.00 |
EPS (Diluted) | -4.37 | -4.85 | -88.13 | -408.60 | -274.80 | -156.00 |
Free Cash Flow | -19.3 | -16.35 | -69.03 | -126.87 | -128.02 | -73.39 |
Free Cash Flow Per Share | -0.01 | -3.00 | -54.31 | -222.97 | -265.58 | -159.09 |
Gross Margin | 46.97% | 46.25% | 1.23% | 26.49% | 21.38% | 21.55% |
Operating Margin | -114.03% | -116.95% | -337.87% | -595.98% | -473.70% | -428.79% |
Profit Margin | -109.95% | -92.59% | -363.97% | -643.74% | -476.93% | -402.84% |
FCF Margin | -67.15% | -57.33% | -224.28% | -351.29% | -460.46% | -408.14% |
EBITDA | -23.16 | -23.61 | -89.76 | -201.33 | -121.86 | -73.73 |
EBITDA Margin | -80.60% | -82.81% | -291.65% | -557.46% | -438.31% | -410.05% |
EBIT | -32.77 | -33.34 | -103.98 | -215.25 | -131.7 | -77.1 |
EBIT Margin | -114.03% | -116.95% | -337.87% | -595.98% | -473.70% | -428.79% |
Effective Tax Rate | -0.22% | -0.25% | -0.03% | -0.03% | -1.44% | 7.32% |